CIK 0000818033 · Accelerated filer
HERON THERAPEUTICS, INC. /DE/
Sign in to watch- Ticker
- HRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 942875566
- Phone
- 8582514400
- Business address
- 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
- 4 Grant or award Director acquired 37,879 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- SC 13G Stake Amended Statement of Ownership
- 4 Option exercise EVP, Chief Financial Officer acquired 3,874 shares (option exercise)
- 4 Option exercise EVP, Chief Development Officer acquired 3,874 shares (option exercise)
- 4 Option exercise Chief Executive Officer acquired 13,797 shares (option exercise)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Option exercise Chief Executive Officer acquired 13,797 shares (option exercise)
- 4 Option exercise EVP, Chief Development Officer acquired 3,875 shares (option exercise)
- 4 Option exercise EVP, Chief Financial Officer acquired 3,875 shares (option exercise)
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change · Bylaws or fiscal year change · Shareholder vote results
- 4 Option exercise EVP, Chief Financial Officer acquired 12,500 shares (option exercise)
- 4 Option exercise EVP, Chief Development Officer acquired 12,500 shares (option exercise)
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
Page 9 of 77 · 1,527 filings